QuidelOrtho Corp
About QuidelOrtho Corp
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $2.7B
- Net income
- -$1.1B
- Total assets
- $5.8B
- Market cap
- $977.2M
- Operating margin
- -33.7%
- Net margin
- -41.5%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $2.7B
- Operating expenses
- $3.6B
- Operating income
- -$919.2M
- Income tax
- $24.1M
- Net income
- -$1.1B
- EPS (basic)
- $-16.69
- EPS (diluted)
- $-16.69
Balance sheet
- Total assets
- $5.8B
- Current assets
- $1.4B
- Total liabilities
- $3.8B
- Current liabilities
- $966.1M
- Shareholders’ equity
- -$15.4M
Cash flow
- Operating cash flow
- $105.2M
- Investing cash flow
- -$192.7M
- Financing cash flow
- $155.8M
- Net cash flow
- $71.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $977.2M
- EPS (diluted)
- $-16.69
- Shares outstanding
- 67.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 4, 1981
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $1.1B in FY2025.
- Revenue grew 64% from FY2020 to FY2025.
- Trading 61% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review QuidelOrtho Corp.
Write a review
News about QuidelOrtho Corp
News & sentiment via Polygon.io
